
    
      Thyroidectomy results in unsightly scarring at the anterior neck of the patient. A clinical
      study was conducted to assess the effectiveness of five courses, applied every 4 weeks, of
      laser-assisted drug delivery (LADD) combining a fractional ablative carbon dioxide laser and
      topical 0.05% clobetasol propionate to the treatment of post-thyroidectomy hypertrophic scars
      in patients. Assessments of the scars by the patient themselves according to the patient and
      observer scar assessment scale.
    
  